Throne Jason 4
4 · IDEAYA Biosciences, Inc. · Filed Jun 27, 2024
Insider Transaction Report
Form 4
Throne Jason
VP, General Counsel
Transactions
- Exercise/Conversion
Common Stock
2024-06-27$13.34/sh+6,424$85,696→ 16,424 total - Exercise/Conversion
Stock Option (Right to Buy)
2024-06-27−6,424→ 41,186 totalExercise: $13.34Exp: 2030-06-30→ Common Stock (6,424 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2024-06-27−47,060→ 1,360 totalExercise: $7.01Exp: 2029-10-08→ Common Stock (47,060 underlying) - Exercise/Conversion
Common Stock
2024-06-27$7.01/sh+47,060$329,891→ 63,484 total
Footnotes (2)
- [F1]25% of the shares subject to the option vest on the first anniversary measured from July 1, 2020 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.
- [F2]The shares subject to the option are fully vested and exercisable.